We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Innovative Imaging Method to Revolutionize Microscopy

By LabMedica International staff writers
Posted on 02 Aug 2024
Print article
Image: The TempoSTEM patented technology revolutionizes microscopy by reimagining the logic of imaging (Photo courtesy of turboTEM)
Image: The TempoSTEM patented technology revolutionizes microscopy by reimagining the logic of imaging (Photo courtesy of turboTEM)

Currently, scanning transmission electron microscopes (STEMs) employ a highly focused electron beam that traverses a sample, creating images point by point. Traditionally, at each point, the beam pauses for a constant, predetermined duration to gather signals, akin to how cameras with photographic film function, resulting in uniformly exposed images across all areas. This method continuously exposes the sample to electrons until the set "dwell-time" for each pixel elapses. Although simple to implement, this technique can subject the sample to excessive radiation, potentially altering or destroying it. Now, a pioneering imaging technique utilizing advanced microscopes has significantly reduced the time and radiation needed for imaging. This advancement is particularly beneficial for fields like medicine, where it promises enhanced imaging of sensitive materials, such as biological tissues, which are highly susceptible to damage.

The new method, devised by an international research group led by Trinity College Dublin (Dublin, Ireland), fundamentally rethinks the traditional imaging process. Rather than measuring the number of detected "events" – electrons scattered from various parts of the sample – over a fixed period, this innovative approach employs an event-based detection system that records the time it takes to detect a predetermined number of events. Both methods provide comparable "detection rate" image contrast, but the novel mathematical theory introduced by the team reveals that while the first electron detected at each position offers substantial information for image construction, additional electrons contribute increasingly less information. Importantly, every electron interacting with the specimen carries a similar risk of damage.

This method enables shutting off the illumination precisely when imaging efficiency becomes optimal, thus requiring fewer electrons to produce an image of equal or superior quality. However, the theory alone does not reduce radiation exposure. To implement this reduced radiation mode, the team has patented a system called Tempo STEM, which integrates a high-tech "beam blanker" that can quickly shut off the beam after achieving the desired accuracy at each sample point. This innovative combination of two cutting-edge technologies marks a significant advancement in microscopy capabilities. By enabling the electron beam to be rapidly turned on and off in response to real-time events, a capability not previously available, this approach not only reduces the overall radiation dose needed for high-quality images but also minimizes unnecessary radiation that offers diminishing returns, thereby protecting the sample from potential damage.

“We tend to think of electrons as relatively mild from a radiation perspective, but when they are fired at a tiny biological sample at speeds of around 75% the speed of light, it’s no surprise that they damage these samples,” said Dr. Jon Peters, Trinity, first author of the research published in the leading international journal Science. “This has been a major issue for microscopy, as the images you get back could be unusable, or worse, misleading. This is obviously problematic if you need to make decisions on future battery materials or catalyst development.”

Related Links:
Trinity College Dublin

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Pipet Controller
Stripettor Pro
New
TRAb Immunoassay
Chorus TRAb

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.